Rothenpieler U - Search Results

1

Restenosis after stenting of atherosclerotic renal artery stenosis: is there a rationale for the use of drug-eluting stents?

Zeller T, Rastan A, Rothenpieler U, Müller C. Zeller T, et al. Among authors: rothenpieler u. Catheter Cardiovasc Interv. 2006 Jul;68(1):125-30. doi: 10.1002/ccd.20773. Catheter Cardiovasc Interv. 2006. PMID: 16755597 Review.

2

Long-term results after directional atherectomy of femoro-popliteal lesions.

Zeller T, Rastan A, Sixt S, Schwarzwälder U, Schwarz T, Frank U, Bürgelin K, Müller C, Rothenpieler U, Flügel PC, Tepe G, Neumann FJ. Zeller T, et al. Among authors: rothenpieler u. J Am Coll Cardiol. 2006 Oct 17;48(8):1573-8. doi: 10.1016/j.jacc.2006.07.031. Epub 2006 Sep 26. J Am Coll Cardiol. 2006. PMID: 17045890 Free article.

3

Endovascular therapy of chronic mesenteric ischaemia.

Zeller T, Rastan A, Schwarzwälder U, Schwarz T, Frank U, Bürgelin K, Sixt S, Müller C, Rothenpieler U, Flügel PC, Neumann FJ. Zeller T, et al. Among authors: rothenpieler u. EuroIntervention. 2007 Feb;2(4):444-51. EuroIntervention. 2007. PMID: 19755283

4

Low-molecular-weight iron dextran in the management of renal anaemia in patients on haemodialysis--the IDIRA Study.

Rath T, Florschütz K, Kalb K, Rothenpieler U, Schletter J, Seeger W, Zinn S. Rath T, et al. Among authors: rothenpieler u. Nephron Clin Pract. 2010;114(1):c81-8. doi: 10.1159/000253958. Epub 2009 Nov 3. Nephron Clin Pract. 2010. PMID: 19887827

5

Therapeutic equivalence, long-term efficacy and safety of HX575 in the treatment of anemia in chronic renal failure patients receiving hemodialysis.

Haag-Weber M, Vetter A, Thyroff-Friesinger U; INJ-Study Group. Haag-Weber M, et al. Clin Nephrol. 2009 Nov;72(5):380-90. Clin Nephrol. 2009. PMID: 19863881 Clinical Trial.

6

Peritonitis due to multiresistant Rhizobium radiobacter.

Rothe H, Rothenpieler U. Rothe H, et al. Among authors: rothenpieler u. Perit Dial Int. 2007 Mar-Apr;27(2):214-5. Perit Dial Int. 2007. PMID: 17299163 No abstract available.

7

Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors.

Siegsmund M, Brinkmann U, Scháffeler E, Weirich G, Schwab M, Eichelbaum M, Fritz P, Burk O, Decker J, Alken P, Rothenpieler U, Kerb R, Hoffmeyer S, Brauch H. Siegsmund M, et al. Among authors: rothenpieler u. J Am Soc Nephrol. 2002 Jul;13(7):1847-54. doi: 10.1097/01.asn.0000019412.87412.bc. J Am Soc Nephrol. 2002. PMID: 12089380

8

CC chemokine receptor 5 and renal-transplant survival.

Fischereder M, Luckow B, Hocher B, Wüthrich RP, Rothenpieler U, Schneeberger H, Panzer U, Stahl RA, Hauser IA, Budde K, Neumayer H, Krämer BK, Land W, Schlöndorff D. Fischereder M, et al. Among authors: rothenpieler u. Lancet. 2001 Jun 2;357(9270):1758-61. doi: 10.1016/s0140-6736(00)04898-4. Lancet. 2001. PMID: 11403814

9

Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients.

Keunecke C, Rothenpieler U, Zanker B, Schneeberger H, Illner WD, Theodorakis J, Stangl M, Land W. Keunecke C, et al. Among authors: rothenpieler u. Transplant Proc. 2000 Feb;32(1A Suppl):6S-8S. doi: 10.1016/s0041-1345(00)00808-3. Transplant Proc. 2000. PMID: 10686310 Clinical Trial. No abstract available.

10

Re-expression of the developmental gene Pax-2 during experimental acute tubular necrosis in mice 1.

Imgrund M, Gröne E, Gröne HJ, Kretzler M, Holzman L, Schlöndorff D, Rothenpieler UW. Imgrund M, et al. Among authors: rothenpieler uw. Kidney Int. 1999 Oct;56(4):1423-31. doi: 10.1046/j.1523-1755.1999.00663.x. Kidney Int. 1999. PMID: 10504494 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page